Restoration of Vision and Retinal Responses After Adeno-Associated Virus–Mediated Optogenetic Therapy in Blind Dogs
Authors:
Open Access
- 2 May 2022
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Translational Vision Science & Technology
- Vol. 11 (5) , 24
Abstract
Purpose: Optogenetic gene therapy to render remaining retinal cells light-sensitive in end-stage retinal degeneration is a promising strategy for treatment of individuals blind because of a variety of different inherited retinal degenerations. The clinical trials currently in progress focus on delivery of optogenetic genes to ganglion cells. Delivery of optogenetic molecules to cells in the outer neural retina is predicted to be even more advantageous because it harnesses more of the retinal circuitry. However, this approach has not yet been tested in large animal models. For this reason, we evaluated the safety and efficacy of optogenetic therapy targeting remaining diseased cone photoreceptors in the Rcd1 dog model of retinitis pigmentosa. Methods: Imaging and measures of retinal function and functional vision were carried out, as well as terminal studies evaluating multi-electrode array recordings and histology. Results: Animals remained healthy and active throughout the study and showed improved retinal and visual function as assessed by electroretinography and visual-evoked potentials, improved navigational vision, and improved function of cone photoreceptors and the downstream retinal circuitry. Conclusions: The findings demonstrate that an optogenetic approach targeting the outer retina in a blind large animal model can partially restore vision. Translational Relevance: This work has translational relevance because the approach could potentially be extrapolated to treat humans who are totally blind because of retinal degenerative disease.Keywords
This publication has 43 references indexed in Scilit:
- AAV9 Targets Cone Photoreceptors in the Nonhuman Primate RetinaPLOS ONE, 2013
- Optogenetic therapy for retinitis pigmentosaGene Therapy, 2011
- Virally delivered Channelrhodopsin-2 Safely and Effectively Restores Visual Function in Multiple Mouse Models of BlindnessMolecular Therapy, 2011
- Spectral and Temporal Sensitivity of Cone-Mediated Responses in Mouse Retinal Ganglion CellsThe Journal of Neuroscience, 2011
- Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis PigmentosaScience, 2010
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the VitreousMolecular Therapy, 2009
- The use of canine models of inherited retinal degeneration to test novel therapeutic approachesVeterinary Ophthalmology, 2009
- eNpHR: a Natronomonas halorhodopsin enhanced for optogenetic applicationsBrain Cell Biology, 2008
- Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene TransferMolecular Therapy, 2008
- Evidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutationBritish Journal of Ophthalmology, 2007